EA201892830A1 - Применение ксиборнола в качестве активного агента для лечения вирусных инфекций - Google Patents

Применение ксиборнола в качестве активного агента для лечения вирусных инфекций

Info

Publication number
EA201892830A1
EA201892830A1 EA201892830A EA201892830A EA201892830A1 EA 201892830 A1 EA201892830 A1 EA 201892830A1 EA 201892830 A EA201892830 A EA 201892830A EA 201892830 A EA201892830 A EA 201892830A EA 201892830 A1 EA201892830 A1 EA 201892830A1
Authority
EA
Eurasian Patent Office
Prior art keywords
xybornol
active agent
viral infections
treating viral
human
Prior art date
Application number
EA201892830A
Other languages
English (en)
Inventor
Кристина Бигини
Original Assignee
Абиоген Фарма С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Абиоген Фарма С.П.А. filed Critical Абиоген Фарма С.П.А.
Publication of EA201892830A1 publication Critical patent/EA201892830A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В настоящем документе описано применение ксиборнола в качестве вирулицидного агента для профилактического или терапевтического лечения инфекции, вызванной одним или более вирусами, при этом указанные вирусы включают по меньшей мере один из аденовируса человека (human Adenovirus), риновируса человека (human Rhinovirus), коронавируса человека (human Coronavirus) и их комбинации.
EA201892830A 2016-07-15 2017-07-13 Применение ксиборнола в качестве активного агента для лечения вирусных инфекций EA201892830A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102016000074507A IT201600074507A1 (it) 2016-07-15 2016-07-15 Uso di xibornolo come agente attivo nel trattamento di infezioni virali
PCT/IB2017/054247 WO2018011751A1 (en) 2016-07-15 2017-07-13 Use of xibornol as active agent in the treatment of viral infections

Publications (1)

Publication Number Publication Date
EA201892830A1 true EA201892830A1 (ru) 2019-08-30

Family

ID=57708665

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892830A EA201892830A1 (ru) 2016-07-15 2017-07-13 Применение ксиборнола в качестве активного агента для лечения вирусных инфекций

Country Status (14)

Country Link
US (1) US10736856B2 (ru)
EP (1) EP3484460A1 (ru)
JP (1) JP2019520373A (ru)
KR (1) KR20190040185A (ru)
CN (1) CN109640968A (ru)
AU (1) AU2017294686B2 (ru)
BR (1) BR112019000711A2 (ru)
CA (1) CA3030657A1 (ru)
EA (1) EA201892830A1 (ru)
IT (1) IT201600074507A1 (ru)
MA (1) MA45678A (ru)
MX (1) MX2019000645A (ru)
PH (1) PH12019500103A1 (ru)
WO (1) WO2018011751A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210095081A1 (en) * 2019-09-26 2021-04-01 Chang Chun Petrochemical Co., Ltd. Polymeric film and laminated glass containing the same

Also Published As

Publication number Publication date
AU2017294686B2 (en) 2019-10-31
KR20190040185A (ko) 2019-04-17
PH12019500103A1 (en) 2019-10-28
BR112019000711A2 (pt) 2019-05-14
IT201600074507A1 (it) 2018-01-15
JP2019520373A (ja) 2019-07-18
MX2019000645A (es) 2019-06-13
CN109640968A (zh) 2019-04-16
WO2018011751A1 (en) 2018-01-18
MA45678A (fr) 2019-05-22
AU2017294686A1 (en) 2019-01-31
US10736856B2 (en) 2020-08-11
EP3484460A1 (en) 2019-05-22
US20190336456A1 (en) 2019-11-07
CA3030657A1 (en) 2018-01-18

Similar Documents

Publication Publication Date Title
BR112021024310A2 (pt) Peptidomiméticos para o tratamento de infecções por coronavírus e picornavírus
DK3597646T3 (da) Terapeutiske forbindelser egnede til den profylaktiske eller terapeutiske behandling af en hiv-virusinfektion
EA201791515A1 (ru) Соединения пиразина для лечения инфекционных заболеваний
BR112017002332A2 (pt) terapia de combinação para o tratamento de um paramixovírus
EA201992329A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
EA201992784A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
CL2019003126A1 (es) Métodos de tratamiento mediante el uso de un compuesto inhibidor de jak.
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
CO2019009215A2 (es) Sal hemi-sulfato de nucleótido para el tratamiento del virus de la hepatitis c
EA201792429A1 (ru) Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге
MX2022000453A (es) Compuestos útiles para tratar infecciones por virus de influenza.
EA201992334A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
EA201892216A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
BR112017022768A2 (pt) desinfecção de tecido com ondas de choque de pressão acústica
EA201790700A1 (ru) Моно- или дизамещенные индолы в качестве ингибиторов репликации вирусов денге
EA201791614A1 (ru) Производные индола в качестве ингибиторов репликации вирусов денге
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EA201790383A1 (ru) Композиции и способы лечения и профилактики инфекций области хирургического вмешательства
CL2022000531A1 (es) Composiciones y métodos para el tratamiento de infecciones virales.
WO2016086153A3 (en) Use of hsp90 inhibitors for the treatment of hiv infections and aids
WO2020055858A8 (en) Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
BR112017023425A2 (pt) combinações terapêuticas de terapias antivirais e anti-inflamatórias
MX2019004029A (es) Compuestos y metodos para diagnosis y tratamiento de infecciones virales.
EA202090693A1 (ru) Новый ингибитор mek для лечения вирусных и бактериальных инфекций